Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

A Multicenter, International Cohort Analysis of 1435 Cases to Support Clinical Trial Design in Acute Pancreatitis.

Farkas N, Hanák L, Mikó A, Bajor J, Sarlós P, Czimmer J, Vincze Á, Gódi S, Pécsi D, Varjú P, Márta K, Hegyi PJ, Erőss B, Szakács Z, Takács T, Czakó L, Németh B, Illés D, Kui B, Darvasi E, Izbéki F, Halász A, Dunás-Varga V, Gajdán L, Hamvas J, Papp M, Földi I, Fehér KE, Varga M, Csefkó K, Török I, Hunor-Pál F, Mickevicius A, Maldonado ER, Sallinen V, Novák J, Ince AT, Galeev S, Bod B, Sümegi J, Pencik P, Szepes A, Szentesi A, Párniczky A, Hegyi P.

Front Physiol. 2019 Sep 4;10:1092. doi: 10.3389/fphys.2019.01092. eCollection 2019.

2.

Clinical, pathological, and genomic features of EWSR1-PATZ1 fusion sarcoma.

Bridge JA, Sumegi J, Druta M, Bui MM, Henderson-Jackson E, Linos K, Baker M, Walko CM, Millis S, Brohl AS.

Mod Pathol. 2019 Nov;32(11):1593-1604. doi: 10.1038/s41379-019-0301-1. Epub 2019 Jun 12.

PMID:
31189996
3.

Antibiotic therapy in acute pancreatitis: From global overuse to evidence based recommendations.

Párniczky A, Lantos T, Tóth EM, Szakács Z, Gódi S, Hágendorn R, Illés D, Koncz B, Márta K, Mikó A, Mosztbacher D, Németh BC, Pécsi D, Szabó A, Szücs Á, Varjú P, Szentesi A, Darvasi E, Erőss B, Izbéki F, Gajdán L, Halász A, Vincze Á, Szabó I, Pár G, Bajor J, Sarlós P, Czimmer J, Hamvas J, Takács T, Szepes Z, Czakó L, Varga M, Novák J, Bod B, Szepes A, Sümegi J, Papp M, Góg C, Török I, Huang W, Xia Q, Xue P, Li W, Chen W, Shirinskaya NV, Poluektov VL, Shirinskaya AV, Hegyi PJ, Bátovský M, Rodriguez-Oballe JA, Salas IM, Lopez-Diaz J, Dominguez-Munoz JE, Molero X, Pando E, Ruiz-Rebollo ML, Burgueño-Gómez B, Chang YT, Chang MC, Sud A, Moore D, Sutton R, Gougol A, Papachristou GI, Susak YM, Tiuliukin IO, Gomes AP, Oliveira MJ, Aparício DJ, Tantau M, Kurti F, Kovacheva-Slavova M, Stecher SS, Mayerle J, Poropat G, Das K, Marino MV, Capurso G, Małecka-Panas E, Zatorski H, Gasiorowska A, Fabisiak N, Ceranowicz P, Kuśnierz-Cabala B, Carvalho JR, Fernandes SR, Chang JH, Choi EK, Han J, Bertilsson S, Jumaa H, Sandblom G, Kacar S, Baltatzis M, Varabei AV, Yeshy V, Chooklin S, Kozachenko A, Veligotsky N, Hegyi P; Hungarian Pancreatic Study Group.

Pancreatology. 2019 Jun;19(4):488-499. doi: 10.1016/j.pan.2019.04.003. Epub 2019 Apr 19.

PMID:
31068256
4.

Prospective, Multicentre, Nationwide Clinical Data from 600 Cases of Acute Pancreatitis.

Párniczky A, Kui B, Szentesi A, Balázs A, Szűcs Á, Mosztbacher D, Czimmer J, Sarlós P, Bajor J, Gódi S, Vincze Á, Illés A, Szabó I, Pár G, Takács T, Czakó L, Szepes Z, Rakonczay Z, Izbéki F, Gervain J, Halász A, Novák J, Crai S, Hritz I, Góg C, Sümegi J, Golovics P, Varga M, Bod B, Hamvas J, Varga-Müller M, Papp Z, Sahin-Tóth M, Hegyi P; Hungarian Pancreatic Study Group.

PLoS One. 2016 Oct 31;11(10):e0165309. doi: 10.1371/journal.pone.0165309. eCollection 2016.

5.

Genetic analysis of the bicarbonate secreting anion exchanger SLC26A6 in chronic pancreatitis.

Balázs A, Ruffert C, Hegyi E, Hritz I, Czakó L, Takács T, Szepes Z, Németh BC, Gervain J, Izbéki F, Halász A, Kelemen D, Szmola R, Novák J, Crai S, Illés A, Vincze Á, Molnár Z, Varga M, Bod B, Farkas G Jr, Sümegi J, Szepes A, Dubravcsik Z, Lásztity N, Párniczky A, Hamvas J, Andorka C, Veres G, Szentkereszty Z, Rakonczay Z Jr, Maléth J, Sahin-Tóth M, Rosendahl J, Hegyi P; Hungarian Pancreatic Study Group.

Pancreatology. 2015 Sep-Oct;15(5):508-513. doi: 10.1016/j.pan.2015.08.008. Epub 2015 Sep 1.

PMID:
26372434
6.

MicroRNA activation signature in patients with hemophagocytic lymphohistiocytosis and reversibility with disease-specific therapy.

Sumegi J, Nestheide S, Aronow B, Fletcher D, Keddache M, Villanueva J, Zhang K, Filipovich AH.

J Allergy Clin Immunol. 2016 Jan;137(1):309-312. doi: 10.1016/j.jaci.2015.06.006. Epub 2015 Jul 17. No abstract available.

PMID:
26194545
7.

Pharmacologic inhibition of epigenetic modification reveals targets of aberrant promoter methylation in Ewing sarcoma.

Nestheide S, Bridge JA, Barnes M, Frayer R, Sumegi J.

Pediatr Blood Cancer. 2013 Sep;60(9):1437-46. doi: 10.1002/pbc.24526. Epub 2013 Mar 18.

PMID:
23508900
8.

Molecular genetic characterization of novel sphingomyelin phosphodiesterase 1 mutations causing niemann-pick disease.

Tóth B, Erdős M, Székely A, Ritli L, Bagossi P, Sümegi J, Maródi L.

JIMD Rep. 2012;3:125-9. doi: 10.1007/8904_2011_80. Epub 2011 Sep 27.

9.

Gene-expression signatures differ between different clinical forms of familial hemophagocytic lymphohistiocytosis.

Sumegi J, Nestheide SV, Barnes MG, Villanueva J, Zhang K, Grom AA, Filipovich AH.

Blood. 2013 Feb 14;121(7):e14-24. doi: 10.1182/blood-2012-05-425769. Epub 2012 Dec 20.

10.

Identification of a novel, recurrent SLC44A1-PRKCA fusion in papillary glioneuronal tumor.

Bridge JA, Liu XQ, Sumegi J, Nelson M, Reyes C, Bruch LA, Rosenblum M, Puccioni MJ, Bowdino BS, McComb RD.

Brain Pathol. 2013 Mar;23(2):121-8. doi: 10.1111/j.1750-3639.2012.00612.x. Epub 2012 Jul 23.

PMID:
22725730
11.

Somato-dendritic morphology and dendritic signal transfer properties differentiate between fore- and hindlimb innervating motoneurons in the frog Rana esculenta.

Stelescu A, Sümegi J, Wéber I, Birinyi A, Wolf E.

BMC Neurosci. 2012 Jun 18;13:68. doi: 10.1186/1471-2202-13-68.

12.

Pericytoma with t(7;12) and ACTB-GLI1 fusion arising in bone.

Bridge JA, Sanders K, Huang D, Nelson M, Neff JR, Muirhead D, Walker C, Seemayer TA, Sumegi J.

Hum Pathol. 2012 Sep;43(9):1524-9. doi: 10.1016/j.humpath.2012.01.019. Epub 2012 May 9.

13.

Assessment of minimal residual disease in ewing sarcoma.

Wagner LM, Smolarek TA, Sumegi J, Marmer D.

Sarcoma. 2012;2012:780129. doi: 10.1155/2012/780129. Epub 2012 Mar 12.

14.

Gene expression profiling of peripheral blood mononuclear cells from children with active hemophagocytic lymphohistiocytosis.

Sumegi J, Barnes MG, Nestheide SV, Molleran-Lee S, Villanueva J, Zhang K, Risma KA, Grom AA, Filipovich AH.

Blood. 2011 Apr 14;117(15):e151-60. doi: 10.1182/blood-2010-08-300046. Epub 2011 Feb 16.

15.

A novel t(4;22)(q31;q12) produces an EWSR1-SMARCA5 fusion in extraskeletal Ewing sarcoma/primitive neuroectodermal tumor.

Sumegi J, Nishio J, Nelson M, Frayer RW, Perry D, Bridge JA.

Mod Pathol. 2011 Mar;24(3):333-42. doi: 10.1038/modpathol.2010.201. Epub 2010 Nov 26.

16.

C11orf95-MKL2 is the resulting fusion oncogene of t(11;16)(q13;p13) in chondroid lipoma.

Huang D, Sumegi J, Dal Cin P, Reith JD, Yasuda T, Nelson M, Muirhead D, Bridge JA.

Genes Chromosomes Cancer. 2010 Sep;49(9):810-8. doi: 10.1002/gcc.20788.

17.

Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family.

Sumegi J, Streblow R, Frayer RW, Dal Cin P, Rosenberg A, Meloni-Ehrig A, Bridge JA.

Genes Chromosomes Cancer. 2010 Mar;49(3):224-36. doi: 10.1002/gcc.20731.

18.

Aberrations of 6q13 mapped to the COL12A1 locus in chondromyxoid fibroma.

Yasuda T, Nishio J, Sumegi J, Kapels KM, Althof PA, Sawyer JR, Reith JD, Bridge JA.

Mod Pathol. 2009 Nov;22(11):1499-506. doi: 10.1038/modpathol.2009.101. Epub 2009 Jul 31.

19.

Association of renal ectopia with Fabry's disease in 3 patients.

Rákóczi E, Tóth B, Görögh S, Erdos M, Sümegi J, Maródi L.

J Urol. 2009 Apr;181(4):1949-54. doi: 10.1016/j.juro.2008.11.091. Epub 2009 Feb 23.

PMID:
19237168
20.

Functional assessment of perforin C2 domain mutations illustrates the critical role for calcium-dependent lipid binding in perforin cytotoxic function.

Urrea Moreno R, Gil J, Rodriguez-Sainz C, Cela E, LaFay V, Oloizia B, Herr AB, Sumegi J, Jordan MB, Risma KA.

Blood. 2009 Jan 8;113(2):338-46. doi: 10.1182/blood-2008-08-172924. Epub 2008 Oct 16.

21.

Genotype-phenotype study of familial haemophagocytic lymphohistiocytosis due to perforin mutations.

Trizzino A, zur Stadt U, Ueda I, Risma K, Janka G, Ishii E, Beutel K, Sumegi J, Cannella S, Pende D, Mian A, Henter JI, Griffiths G, Santoro A, Filipovich A, Aricò M; Histiocyte Society HLH Study group.

J Med Genet. 2008 Jan;45(1):15-21. Epub 2007 Sep 14.

PMID:
17873118
22.

Severe Shwachman-Diamond syndrome phenotype caused by compound heterozygous missense mutations in the SBDS gene.

Erdos M, Alapi K, Balogh I, Oroszlán G, Rákóczi E, Sümegi J, Maródi L.

Exp Hematol. 2006 Nov;34(11):1517-21.

PMID:
17046571
23.

Patients of African ancestry with hemophagocytic lymphohistiocytosis share a common haplotype of PRF1 with a 50delT mutation.

Lee SM, Sumegi J, Villanueva J, Tabata Y, Zhang K, Chakraborty R, Sheng X, Clementi R, de Saint Basile G, Filipovich AH.

J Pediatr. 2006 Jul;149(1):134-7.

PMID:
16860143
24.

[Laparoscopic colon operations for endoscopically unremovable polyps and tumors].

Bezsilla J, Bende S, Varga L, Botos A, Liptay-Wagner P, Sikorszki L, Sümegi J, Nagy G.

Magy Seb. 2005 Oct;58(5):305-10. Hungarian.

PMID:
16496772
25.

Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis.

Risma KA, Frayer RW, Filipovich AH, Sumegi J.

J Clin Invest. 2006 Jan;116(1):182-92. Epub 2005 Dec 22.

26.

Characterization of a new disease-causing mutation of SH2D1A in a family with X-linked lymphoproliferative disease.

Erdõs M, Uzvölgyi E, Nemes Z, Török O, Rákóczi E, Went-Sümegi N, Sümegi J, Maródi L.

Hum Mutat. 2005 May;25(5):506.

PMID:
15841490
27.

[Endoscopic retrograde cholangio-pancreatography after conventional Billroth II resection].

Sümegi J.

Orv Hetil. 2004 Nov 28;145(48):2425-30. Hungarian.

PMID:
15638036
28.

Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members.

Tabata Y, Villanueva J, Lee SM, Zhang K, Kanegane H, Miyawaki T, Sumegi J, Filipovich AH.

Blood. 2005 Apr 15;105(8):3066-71. Epub 2005 Jan 4.

PMID:
15632210
29.

[Laparoscopic exploration of the common bile duct].

Bezsilla J, Sümegi J, Botos A, Liptay-Wagner P, Sikorszki L, Bende S.

Magy Seb. 2004 Apr;57(2):68-72. Hungarian.

PMID:
15270527
30.

SAP increases FynT kinase activity and is required for phosphorylation of SLAM and Ly9.

Simarro M, Lanyi A, Howie D, Poy F, Bruggeman J, Choi M, Sumegi J, Eck MJ, Terhorst C.

Int Immunol. 2004 May;16(5):727-36. Epub 2004 Apr 13.

PMID:
15096483
31.

Characterisation of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with haemophagocytic lymphohistiocytosis.

Molleran Lee S, Villanueva J, Sumegi J, Zhang K, Kogawa K, Davis J, Filipovich AH.

J Med Genet. 2004 Feb;41(2):137-44. No abstract available.

32.

Mice deficient in the X-linked lymphoproliferative disease gene sap exhibit increased susceptibility to murine gammaherpesvirus-68 and hypo-gammaglobulinemia.

Yin L, Al-Alem U, Liang J, Tong WM, Li C, Badiali M, Médard JJ, Sumegi J, Wang ZQ, Romeo G.

J Med Virol. 2003 Nov;71(3):446-55.

PMID:
12966553
33.

Identification and characterization of a novel gene disrupted by a pericentric inversion inv(4)(p13.1q21.1) in a family with cleft lip.

Beiraghi S, Zhou M, Talmadge CB, Went-Sumegi N, Davis JR, Huang D, Saal H, Seemayer TA, Sumegi J.

Gene. 2003 Apr 24;309(1):11-21.

PMID:
12727354
34.

Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor.

Ma Z, Hill DA, Collins MH, Morris SW, Sumegi J, Zhou M, Zuppan C, Bridge JA.

Genes Chromosomes Cancer. 2003 May;37(1):98-105.

PMID:
12661011
35.

SAP couples Fyn to SLAM immune receptors.

Chan B, Lanyi A, Song HK, Griesbach J, Simarro-Grande M, Poy F, Howie D, Sumegi J, Terhorst C, Eck MJ.

Nat Cell Biol. 2003 Feb;5(2):155-60.

PMID:
12545174
36.

Identification of the mouse and rat orthologs of the gene mutated in Usher syndrome type IIA and the cellular source of USH2A mRNA in retina, a target tissue of the disease.

Huang D, Eudy JD, Uzvolgyi E, Davis JR, Talmadge CB, Pretto D, Weston MD, Lehman JE, Zhou M, Seemayer TA, Ahmad I, Kimberling WJ, Sumegi J.

Genomics. 2002 Aug;80(2):195-203.

PMID:
12160733
37.

A spectrum of mutations in SH2D1A that causes X-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnesses.

Sumegi J, Seemayer TA, Huang D, Davis JR, Morra M, Gross TG, Yin L, Romco G, Klein E, Terhorst C, Lanyi A.

Leuk Lymphoma. 2002 Jun;43(6):1189-201. Review.

PMID:
12152986
38.

Usher syndrome type III: revised genomic structure of the USH3 gene and identification of novel mutations.

Fields RR, Zhou G, Huang D, Davis JR, Möller C, Jacobson SG, Kimberling WJ, Sumegi J.

Am J Hum Genet. 2002 Sep;71(3):607-17. Epub 2002 Jul 16.

39.

Ex vivo purging by adenoviral p53 gene therapy does not affect NOD-SCID repopulating activity of human CD34+ cells.

Hirai M, LaFace D, Robinson S, Kelsey L, Johnson R, Wen SF, Warkentin P, Mills K, Vaillancourt M, Chavez J, Leutzinger C, Sumegi J, Neugebauer S, Lehman J, Talmadge C, Maneval D, Talmadge J.

Cancer Gene Ther. 2001 Dec;8(12):936-47.

40.

Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members.

Kogawa K, Lee SM, Villanueva J, Marmer D, Sumegi J, Filipovich AH.

Blood. 2002 Jan 1;99(1):61-6.

PMID:
11756153
41.

Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients.

Morra M, Simarro-Grande M, Martin M, Chen AS, Lanyi A, Silander O, Calpe S, Davis J, Pawson T, Eck MJ, Sumegi J, Engel P, Li SC, Terhorst C.

J Biol Chem. 2001 Sep 28;276(39):36809-16. Epub 2001 Jul 26.

42.

Molecular genetics of Usher syndrome.

Eudy JD, Sumegi J.

Cell Mol Life Sci. 1999 Oct 15;56(3-4):258-67. Review.

PMID:
11212353
43.

SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines.

Nagy N, Cerboni C, Mattsson K, Maeda A, Gogolák P, Sümegi J, Lányi A, Székely L, Carbone E, Klein G, Klein E.

Int J Cancer. 2000 Nov 1;88(3):439-47.

44.

Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.

Sumegi J, Huang D, Lanyi A, Davis JD, Seemayer TA, Maeda A, Klein G, Seri M, Wakiguchi H, Purtilo DT, Gross TG.

Blood. 2000 Nov 1;96(9):3118-25.

PMID:
11049992
45.
46.

Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa.

Weston MD, Eudy JD, Fujita S, Yao S, Usami S, Cremers C, Greenberg J, Ramesar R, Martini A, Moller C, Smith RJ, Sumegi J, Kimberling WJ.

Am J Hum Genet. 2000 Apr;66(4):1199-210. Epub 2000 Mar 22. Erratum in: Am J Hum Genet 2000 Jun;66(6):2020. Greenburg J [corrected to Greenberg J].

47.

Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition.

Poy F, Yaffe MB, Sayos J, Saxena K, Morra M, Sumegi J, Cantley LC, Terhorst C, Eck MJ.

Mol Cell. 1999 Oct;4(4):555-61.

48.

Analysis of NotI linking clones isolated from human chromosome 3 specific libraries.

Kashuba VI, Gizatullin RZ, Protopopov AI, Li J, Vorobieva NV, Fedorova L, Zabarovska VI, Muravenko OV, Kost-Alimova M, Domninsky DA, Kiss C, Allikmets R, Zakharyev VM, Braga EA, Sumegi J, Lerman M, Wahlestedt C, Zelenin AV, Sheer D, Winberg G, Grafodatsky A, Kisselev LL, Klein G, Zabarovsky ER.

Gene. 1999 Nov 1;239(2):259-71.

PMID:
10548727
49.

The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors.

Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA, Jones PA.

Nucleic Acids Res. 1999 Jun 1;27(11):2291-8.

50.

The molecular genetics of X-linked lymphoproliferative (Duncan's) disease.

Sumegi J, Gross TG, Seemayer TA.

Cancer J Sci Am. 1999 Mar-Apr;5(2):57-62. Review. No abstract available.

PMID:
10198724

Supplemental Content

Loading ...
Support Center